Pursuant to Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Link Pharma Chem has informed that the Board has at its meeting held on today approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2023. The company has enclosed Unaudited Financial Results along with Limited Review Report for the quarter ended on June 30, 2023. The meeting of the Board of Directors commenced at 11:30 am and concluded at 02:45 pm.
The above information is a part of company’s filings submitted to BSE.
